Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) had Cash Flow from Financial Activities of $10.94M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.26M |
|
$1.97M |
|
$9.19M |
|
$18.89M |
|
$6.43M |
|
$0.15M |
|
$1.82M |
|
$8.25M |
|
$10.63M |
|
$3.42M |
|
$10.63M |
|
-- |
|
| Cash Flow Statement Financials | |
$-15.67M |
|
$-0.76M |
|
|
Cash Flow from Financial Activities |
$10.94M |
$7.63M |
|
$2.13M |
|
$-5.50M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|